Health Trials

Alcohol Liver Disease

2

Review clinical trials related to Alcohol Liver Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of pemvidutide in subjects with ALD. * Pemvidutide: 2.4 mg SC once weekly * Placebo: Placebo SC once weekly

Participants needed: 100
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Altimmune, Inc.Updated: Mar 20, 2026Locations: 43
Eligibility criteria

Male or female ages 18 to 75 years, inclusive [+3]

Presence of clinically significant alcohol withdrawal symptoms, defined as CIWA-... [+3]

Read more
Status: Not yet recruiting

Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.

This is a retrospective cross-sectional research intended to explore the utility of LIVERFASt in the clinical pathways for the detection of liver fibrosis and steatosis in comparison with the Magnetic Resonance Elastography (MRE) and MRct1 fibrosis classification (historical records) and to assess LIVERFASt performance for MR steatosis assessment in an United States adult miscellaneous population with available (historical) MR intracellular fat fraction assessment (ICFF) from a single tertiary US clinic.

Participants needed: 100
Trial details
Age: 18-90Biological sex: AllType: ObservationalSponsor: Fibronostics USA, IncUpdated: Mar 13, 2025Locations: 1Duration: 2 Days
Eligibility criteria

available historical report of MRE and LIVERFASt test [+2]

Participants identified as having risk factors for false positive/negative resul... [+1]

Read more